awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33642238-B8A3F577-EF6D-4DCF-AAF2-549DCDC06DD4
Q33642238-B8A3F577-EF6D-4DCF-AAF2-549DCDC06DD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33642238-B8A3F577-EF6D-4DCF-AAF2-549DCDC06DD4
Assessment of Obesity and Hepatic Late Adverse Effects in the Egyptian Survivors of Pediatric Acute Lymphoblastic Leukemia: a Single Center Study.
P2860
Q33642238-B8A3F577-EF6D-4DCF-AAF2-549DCDC06DD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33642238-B8A3F577-EF6D-4DCF-AAF2-549DCDC06DD4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2316861d49dfe9cd7cabea258f5a57d2eba2a438
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).